A nicotine by-product reacts with proteins, say scientists at TSRI

October 28, 2002

October 24, 2002, La Jolla, CA--Two researchers at The Scripps Research Institute (TSRI) have discovered that a chemical called nornicotine-- which is naturally present in tobacco and is also produced as a metabolite of nicotine-- may contribute to the pathology of diabetes, cancer, aging, and Alzheimer's disease.

In an article to be published in the Proceedings of the National Academy of Sciences, the researchers have uncovered a previously unrecognized chemical process through which nornicotine reacts with the body's proteins.

"Nornicotine permanently and irreversibly modifies proteins, which can affect their overall function," says Kim Janda, Ph.D., who holds the Ely R. Callaway, Jr. Chair in Chemistry at TSRI.

This process is the chemical equivalent of cooking and is the same reaction that browns seared sugars and that causes food to age and spoil. Furthermore, the "cooking" of proteins is just the tip of the icebergnornicotine also reacts with commonly prescribed steroids, like cortisone and prednisone, potentially making them more toxic or compromising the effectiveness and safety of these drugs.

How Nornicotine "Cooks" Proteins
The chemical nornicotine attaches itself "covalently" (permanently) to steroids and to certain amino acids on the surface of proteins. These modified steroids and proteins can then interact with other chemicals in the body. Significantly, nornicotine-modified proteins can react to form a variety of compounds known as advanced glycation endproducts.

"These advanced glycation endproducts are not supposed to be [present in your body] naturally," says Tobin Dickerson, a Ph.D. student in TSRI's Kellogg School of Science and Technology. "Your body is not prepared for them."

Advanced glycation endproducts have previously been implicated in numerous diseases including diabetes, cancer, atherosclerosis, and Alzheimer's disease. Dickerson and Janda's study shows a direct link between tobacco use and the development of these advanced glycation endproducts.

When they tested the blood of smokers and non-smokers, they found that the smokers had higher levels of the nornicotine-modified proteins than non-smokers. The smokers also had higher levels of the advanced glycation endproducts.

The persistence of nornicotine in the bloodstreamas opposed to nicotine, which quickly disappears after cessation of smokingmay also suggest a role for nornicotine in contributing to the biological mechanisms of tobacco addiction, since the nornicotine provides a long-lived source of nicotine-like molecules.

The work highlights the need for more studies into the consequences of exposing the human body to nicotine metabolites, like nornicotine.

The article, "A previously undescribed chemical link between smoking and metabolic disease" was authored by Tobin J. Dickerson and Kim D. Janda and appears in the October 28, 2002 online edition of the journal Proceedings of the National Academy of Sciences. The article will appear in print later this year.
-end-
This work was supported by the Skaggs Institute for Chemical Biology.

Scripps Research Institute

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.